/

AbbVie Inc.

ABBV US

ABBV USAbbVie Inc.

United States Composite

167.89

USD

+1.48

(+0.89%)

2.74EPS Dil.

61.04P/E

296.48BMarket Cap

3.55%Div. Yield

AbbVie Inc.

ABBV

(United States Composite)

Recent

price

167.89

P/E

ratio

61.04

div

yld

3.55%

ROIC.AI

Legends:

Stock price

0.56

Beta (1.0 Market)

% total return 04/23

Stock

S&P500

YTD

9.53

- -

59.71

- -

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

FRC

- -

8.80

9.68

10.79

11.66

11.83

12.51

14.07

15.81

17.68

21.25

22.46

27.48

31.75

32.78

30.72

- -

2.87

2.59

2.12

3.34

2.60

1.11

3.17

3.67

3.33

3.69

5.32

2.77

6.52

6.68

2.75

- -

3.13

2.80

3.65

3.81

3.63

1.84

4.31

4.05

5.91

8.30

8.62

10.07

12.42

13.69

12.48

- -

1.61

1.67

2.03

2.29

2.57

3.62

4.30

4.63

5.23

5.67

5.96

- -

7.36

2.35

1.00

0.35

1.41

2.76

3.44

2.29

3.20

0.61

1.78

2.71

-0.56

- -

3.58

1.80

-3.22

-2.32

-3.54

-17.97

-24.91

-24.02

-30.66

-28.69

-58.30

-52.53

-46.52

-43.89

- -

1,616

1,577

1,589

1,595

1,625

1,622

1,596

1,541

1,481

1,667

1,770

1,771

1,768

- -

14,214

15,638

17,444

18,380

18,790

19,960

22,859

25,638

28,216

32,753

33,266

45,804

56,197

58,054

54,318

- -

35.89

32.17

24.61

33.22

31.94

18.85

33.63

37.21

34.99

20.78

40.19

27.81

33.90

32.41

24.92

- -

697

1,184

1,272

1,150

897

786

836

1,189

1,501

1,765

2,017

6,471

8,521

8,467

8,698

- -

4,637

4,178

3,433

5,275

4,128

1,774

5,144

5,953

5,309

5,687

7,882

4,616

11,542

11,836

4,863

- -

22.08

13.61

6.41

7.86

22.58

25.12

22.59

24.49

31.29

- -

6.46

- -

11.09

12.11

22.03

- -

32.62

26.72

19.68

28.70

21.97

8.89

22.50

23.22

18.82

17.36

23.69

10.08

20.54

20.39

8.95

- -

4,457

1,457

8,578

10,969

4,688

5,420

6,406

4,582

-294

33,934

-4,488

-7,266

-1,075

-4,839

- -

14,630

14,292

10,538

29,240

36,440

30,953

35,002

62,975

77,554

64,189

59,135

52,194

- -

15,703

11,932

3,363

4,492

1,742

3,945

4,636

5,097

-8,446

-8,172

13,097

15,436

17,287

10,397

- -

55.89

29.36

36.46

24.30

15.68

22.74

18.69

16.16

- -

27.69

- -

17.71

19.15

14.04

- -

57.19

34.22

24.43

13.16

23.05

17.94

14.51

- -

16.59

- -

16.39

18.64

10.41

- -

57.42

67.33

155.89

166.26

365.34

178.74

107.55

128.33

194.11

158.95

547.27

297.87

- -

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

5,203

5,115

7,191

LT Borrowings

55,812

55,631

52,194

LT Finance Leases

- -

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

1,765

1,766

Market Capitalization

237,771

263,163

273,668

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

28,852

33,224

33,002

Cash, Cash Equivalents & STI

8,766

13,290

12,816

Accounts Receivable, Net

11,491

11,412

11,155

Inventories

4,055

3,981

4,099

Total Current Liabilities

32,239

34,773

37,841

Payables & Accruals

27,036

29,658

30,650

ST Debt

5,203

5,115

7,191

Deferred Revenue

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

11.79%

11.76%

-6.44%

Net Income, GAAP

23.58%

18.17%

-58.91%

Free Cash Flow

22.59%

12.71%

-9.02%

Total Cash Common Dividend

15.58%

13.74%

4.94%

Total Equity

-44.00%

-53.41%

-39.86%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

13,010

13,959

14,342

14,886

56,197

2022

13,538

14,583

14,812

15,121

58,054

2023

12,225

13,865

13,927

14,301

54,318

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

2.01

0.43

1.80

2.28

6.52

2022

2.54

0.52

2.23

1.40

6.68

2023

0.14

1.15

1.01

0.46

2.75

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

1.31

5.23

2022

1.43

1.42

1.41

1.42

5.67

2023

1.50

1.49

5.96

Business: AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Company News

Tipranks
20 days ago
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV)
Reuters
21 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Yahoo
21 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Yahoo
21 days ago
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript
Reuters
21 days ago
Roivant's anti-inflammatory drug succeeds in mid-stage study
FOOL
21 days ago
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
Yahoo
22 days ago
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks
22 days ago
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks
22 days ago
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks
22 days ago
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Yahoo
22 days ago
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Zacks
22 days ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Tipranks
22 days ago
This Biopharma Stock Outperforms MSTR and SMCI in March 2024
FOOL
24 days ago
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
Zacks
a month ago
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Yahoo
a month ago
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
CNBC
a month ago
Here are Thursday's biggest analyst calls: Nvidia, Meta, Tesla, Apple, CyberArk, Grindr, Estee Lauder & more
Yahoo
a month ago
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Zacks
a month ago
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Yahoo
a month ago
Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio

Company News

Tipranks
20 days ago
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV)
Reuters
21 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Yahoo
21 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Yahoo
21 days ago
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript
Reuters
21 days ago
Roivant's anti-inflammatory drug succeeds in mid-stage study
FOOL
21 days ago
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
Yahoo
22 days ago
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks
22 days ago
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks
22 days ago
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks
22 days ago
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Yahoo
22 days ago
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Zacks
22 days ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Tipranks
22 days ago
This Biopharma Stock Outperforms MSTR and SMCI in March 2024
FOOL
24 days ago
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
Zacks
a month ago
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Yahoo
a month ago
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
CNBC
a month ago
Here are Thursday's biggest analyst calls: Nvidia, Meta, Tesla, Apple, CyberArk, Grindr, Estee Lauder & more
Yahoo
a month ago
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Zacks
a month ago
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Yahoo
a month ago
Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio

- -

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

FRC

- -

8.80

9.68

10.79

11.66

11.83

12.51

14.07

15.81

17.68

21.25

22.46

27.48

31.75

32.78

30.72

- -

2.87

2.59

2.12

3.34

2.60

1.11

3.17

3.67

3.33

3.69

5.32

2.77

6.52

6.68

2.75

- -

3.13

2.80

3.65

3.81

3.63

1.84

4.31

4.05

5.91

8.30

8.62

10.07

12.42

13.69

12.48

- -

1.61

1.67

2.03

2.29

2.57

3.62

4.30

4.63

5.23

5.67

5.96

- -

7.36

2.35

1.00

0.35

1.41

2.76

3.44

2.29

3.20

0.61

1.78

2.71

-0.56

- -

3.58

1.80

-3.22

-2.32

-3.54

-17.97

-24.91

-24.02

-30.66

-28.69

-58.30

-52.53

-46.52

-43.89

- -

1,616

1,577

1,589

1,595

1,625

1,622

1,596

1,541

1,481

1,667

1,770

1,771

1,768

- -

14,214

15,638

17,444

18,380

18,790

19,960

22,859

25,638

28,216

32,753

33,266

45,804

56,197

58,054

54,318

- -

35.89

32.17

24.61

33.22

31.94

18.85

33.63

37.21

34.99

20.78

40.19

27.81

33.90

32.41

24.92

- -

697

1,184

1,272

1,150

897

786

836

1,189

1,501

1,765

2,017

6,471

8,521

8,467

8,698

- -

4,637

4,178

3,433

5,275

4,128

1,774

5,144

5,953

5,309

5,687

7,882

4,616

11,542

11,836

4,863

- -

22.08

13.61

6.41

7.86

22.58

25.12

22.59

24.49

31.29

- -

6.46

- -

11.09

12.11

22.03

- -

32.62

26.72

19.68

28.70

21.97

8.89

22.50

23.22

18.82

17.36

23.69

10.08

20.54

20.39

8.95

- -

4,457

1,457

8,578

10,969

4,688

5,420

6,406

4,582

-294

33,934

-4,488

-7,266

-1,075

-4,839

- -

14,630

14,292

10,538

29,240

36,440

30,953

35,002

62,975

77,554

64,189

59,135

52,194

- -

15,703

11,932

3,363

4,492

1,742

3,945

4,636

5,097

-8,446

-8,172

13,097

15,436

17,287

10,397

- -

55.89

29.36

36.46

24.30

15.68

22.74

18.69

16.16

- -

27.69

- -

17.71

19.15

14.04

- -

57.19

34.22

24.43

13.16

23.05

17.94

14.51

- -

16.59

- -

16.39

18.64

10.41

- -

57.42

67.33

155.89

166.26

365.34

178.74

107.55

128.33

194.11

158.95

547.27

297.87

- -